Jefferies Group LLC Axogen, Inc. Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$12.09 - $20.46 $140,522 - $237,806	-11,623 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.5 - $25.47 $215,025 - $296,037	11,623 New	11,623 $230,000
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $1.43 Million - $2.08 Million	-39,566 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$24.4 - $40.25 $685,371 - $1.13 Million	-28,089 Reduced 41.52%	39,566 $1.44 Million
Q4 2017 Feb 14, 2018	BUY	$18.5 - $28.6 $1.25 Million - $1.93 Million	67,655	67,655 $1.92 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.